Fig. 3.
Botrocetin-induced binding to platelets of plasma vWF from propositi B1 and D1.
Normal plasma or patient plasma vWF was indirectly labeled with125I-labeled anti-vWF mAb and then incubated with fixed platelets in the presence of botrocetin. The binding was expressed as the percentage of the platelet-bound radioactivity to total radioactivity. Results represent the mean of 2 experiments.
